StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Hualan Biological Bacterin Inc.
Shenzhen Stock Exchange:301207.SZ
Sector
Industries
Location
Market Cap
USD 1.42 B
Share Price
USD 2.36
Avg Daily Volume
2,280,983
Change (1 day)
0.88%
Change (1 year)
2.93%
Change (YTD)
-1.59%
Hualan Biological Bacterin Inc. Revenue Per Share for the year ending December 31, 2024: USD 0.26
Hualan Biological Bacterin Inc. Revenue Per Share is USD 0.26 for the year ending December 31, 2024, a -54.31% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Hualan Biological Bacterin Inc. Revenue Per Share for the year ending December 31, 2023 was USD 0.57, a 28.19% change year over year.
-
Hualan Biological Bacterin Inc. Revenue Per Share for the year ending December 31, 2022 was USD 0.44, a -8.13% change year over year.
-
Hualan Biological Bacterin Inc. Revenue Per Share for the year ending December 31, 2021 was USD 0.48, a -22.53% change year over year.
-
Hualan Biological Bacterin Inc. Revenue Per Share for the year ending December 31, 2020 was USD 0.62, a 146.76% change year over year.
Competitors
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Moderna, Inc.
USD 29.90
MRNA
-0.59
-1.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.37
603392.SS
+0.04
0.44%
Swedish Orphan Biovitrum AB (publ)
USD 29.86
SOBI.ST
-0.18
-0.60%
Ionis Pharmaceuticals, Inc.
USD 41.78
IONS
-1.22
-2.84%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.77
300122.SZ
+0.06
2.20%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.04
1877.HK
-0.11
-3.43%
Vaxcyte, Inc.
USD 32.00
PCVX
-1.25
-3.76%
Rhythm Pharmaceuticals, Inc.
USD 66.39
RYTM
+0.62
0.94%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.49%
Apogee Therapeutics, Inc.
USD 39.24
APGE
-8.22
-17.32%
Apellis Pharmaceuticals, Inc.
USD 17.42
APLS
-0.84
-4.60%
NewAmsterdam Pharma Company N.V.
USD 19.46
NAMS
-0.39
-1.97%
Ligand Pharmaceuticals Incorporated
USD 113.76
LGND
-0.82
-0.72%
Bavarian Nordic A/S
USD 26.56
BAVA.CO
-0.71
-2.61%
Adaptive Biotechnologies Corporation
USD 11.74
ADPT
-0.06
-0.51%
Immunocore Holdings plc
USD 32.41
IMCR
-0.61
-1.85%
ARS Pharmaceuticals, Inc.
USD 17.09
SPRY
+0.57
3.45%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Moderna, Inc.
USD 29.90
MRNA
-0.59
-1.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.37
603392.SS
+0.04
0.44%
Swedish Orphan Biovitrum AB (publ)
USD 29.86
SOBI.ST
-0.18
-0.60%
Ionis Pharmaceuticals, Inc.
USD 41.78
IONS
-1.22
-2.84%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.77
300122.SZ
+0.06
2.20%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.04
1877.HK
-0.11
-3.43%
Vaxcyte, Inc.
USD 32.00
PCVX
-1.25
-3.76%
Rhythm Pharmaceuticals, Inc.
USD 66.39
RYTM
+0.62
0.94%
Hualan Biological Engineering Inc.
USD 2.22
002007.SZ
+0.01
0.49%
Apogee Therapeutics, Inc.
USD 39.24
APGE
-8.22
-17.32%
Apellis Pharmaceuticals, Inc.
USD 17.42
APLS
-0.84
-4.60%
NewAmsterdam Pharma Company N.V.
USD 19.46
NAMS
-0.39
-1.97%
Ligand Pharmaceuticals Incorporated
USD 113.76
LGND
-0.82
-0.72%
Bavarian Nordic A/S
USD 26.56
BAVA.CO
-0.71
-2.61%
Adaptive Biotechnologies Corporation
USD 11.74
ADPT
-0.06
-0.51%
Immunocore Holdings plc
USD 32.41
IMCR
-0.61
-1.85%
ARS Pharmaceuticals, Inc.
USD 17.09
SPRY
+0.57
3.45%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Novo Nordisk A/S
USD 69.09
NOVO-B.CO
-1.99
-2.80%